Level-III, retrospective cohort study.

The perioperative use of NSAIDs in cesarean delivery patients will result in a significantly lower pain scores, less opioid consumption, and less drowsiness/sedation but no difference in nausea or vomiting compared to those who did not receive NSAIDs. Further research should address the optimal NSAID regimen and examine the effect of improved analgesia on patient-centered outcomes such as patient satisfaction and quality of breastfeeding.

(Reg Anesth Pain Med. 2016;41(6):763–772) In 2007, there were 1.4 million cesarean deliveries (1 in 3 live births) in the United States alone. Pain after cesarean delivery can be severe in many patients, with 78% of women undergoing cesarean delivery reporting moderate to severe postoperative pain within the first 24 hours postoperatively. Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in the treatment of this postoperative pain despite them being generally viewed as “weak” analgesics. This meta-analysis was conducted to assess the analgesic efficacy of NSAIDs in postoperative cesarean delivery patients as well as secondary outcomes such as opioid-related adverse side effects and quality of breastfeeding.

We present a case of a child with granulomatosis with polyangiitis, admitted with acute respiratory distress attributed to subglottic stenosis. The anesthetic management and potential complications are described.